Home > Healthcare > Medical Devices > Diagnostic Devices > PCR & NGS Based Diagnostic Testing Market
PCR & NGS Based Diagnostic Testing Market Share
- Report ID: GMI5057
- Published Date: May 2021
- Report Format: PDF
PCR & NGS Based Diagnostic Testing Market Share
Some of the key companies functioning in the PCR & NGS based diagnostic testing market include
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Eppendorf AG
- Fluotics
- Hamilton Company
- Illumina, Inc.
- Integra LifeScience Holdings Corporation
- MGI Tech Co., Ltd
- Mascon, Inc.
- Qiagen Inc
- Roche Diagnostics
- Thermo Fisher Scientific
- Thomas Scientific (The Carlyle Group)
- VWR International (Avantor, Inc.)
These industry leaders have been undergoing strategic developments to sustain the market competition and capture sizable revenue share in the testing industry.
Frequently Asked Questions (FAQ) :
The industry share of PCR & NGS based diagnostic testing was valued at USD 21.5 billion in 2020 and will expand with higher usage in the detection of viruses and other infectious diseases.
The industry revenue from consumable products had reached USD 18.8 billion in 2020 and will grow in the coming years owing to the increasing adoption of disposable products in the PCR and NGS based diagnostic testing.
Diagnostic centers accounted for over 36% of the PCR & NGS based diagnostic testing market share in 2020 and will observe growth due to the presence of latest technologies and apt medical infrastructure.
North America PCR & NGS based diagnostic testing market size is pegged to strike a 1.2% growth rate up to 2027 driven by the rising sales of consumables in the region.
PCR & NGS Based Diagnostic Testing Market Scope
×
Get a free sample of
PCR & NGS Based Diagnostic Testing Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below